Get Your Free Audiobook

Prime logo New to Audible Prime Member exclusive:
2 credits with free trial
1 credit a month to use on any title to download and keep
Listen to anything from the Plus Catalogue—thousands of Audible Originals, podcasts and audiobooks
Download titles to your library and listen offline
₹199 per month after 30-day trial. Cancel anytime.
N of 1 cover art

N of 1

Written by: Glenn Sabin, Dawn Lemanne MD MPH - contributor, Dean Ornish MD - foreword
Narrated by: Charles Constant
Free with 30-day trial

₹199 per month after trial ends. Cancel anytime.

Buy Now for ₹469.00

Buy Now for ₹469.00

Pay using card ending in
By confirming your purchase, you agree to Audible's Conditions of Use and Amazon's Privacy Notice.

Publisher's Summary

Twenty-five years ago, my doctors had no cure for my cancer. So I went on a quest to find my own treatment. This is my story....

In 1991, Glenn Sabin was a 28-year-old newlywed diagnosed with chronic lymphocytic leukemia (CLL) - a disease doctors called "uniformly fatal". Treatments could buy him some time and eventually ease his discomfort, but there was no conventional cure. Glenn's prognosis was clear: He was going to die.

Although Glenn and his wife, Linda, continued to consult with doctors, cancer specialists, and top oncologists, Glenn made a monumental decision: He would become his own health advocate. While he continued to "watch and wait", Glenn would figure out how to stay alive.

No one could predict when a large-scale clinical trial would discover a cure for CLL, so Glenn began his own medically monitored and carefully researched lifestyle changes. He would conduct his own single-patient clinical trial.

He would become an "n of one".

Today, Glenn is not only alive, but a 2012 biopsy at Harvard confirmed that his bone marrow contains no leukemic cells. His case is now part of the medical literature.

©2016 FON Therapeutics, Inc. (P)2020 Tantor

What listeners say about N of 1

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.